| American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer AB Benson III, D Schrag, MR Somerfield, AM Cohen, AT Figueredo, ... Journal of clinical oncology 22 (16), 3408-3419, 2004 | 1764 | 2004 |
| Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 JP Kuebler, HS Wieand, MJ O'Connell, RE Smith, LH Colangelo, ... Journal of clinical oncology 25 (16), 2198-2204, 2007 | 1318 | 2007 |
| Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial PJ Loehrer Sr, Y Feng, H Cardenes, L Wagner, JM Brell, D Cella, P Flynn, ... Journal of Clinical Oncology 29 (31), 4105, 2011 | 929 | 2011 |
| Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). RL Hubbard, SG Craddock, PM Flynn, J Anderson, RM Etheridge Psychology of Addictive Behaviors 11 (4), 261, 1997 | 883 | 1997 |
| Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group–directed intergroup trial … PA Philip, J Benedetti, CL Corless, R Wong, EM O'Reilly, PJ Flynn, ... Journal of clinical oncology 28 (22), 3605, 2010 | 731 | 2010 |
| Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline CE Desch, AB Benson III, MR Somerfield, PJ Flynn, C Krause, CL Loprinzi, ... Journal of Clinical Oncology 23 (33), 8512-8519, 2005 | 731 | 2005 |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ... The lancet oncology 18 (12), 1688-1700, 2017 | 642 | 2017 |
| Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma TE Witzig, SM Geyer, I Ghobrial, DJ Inwards, R Fonseca, P Kurtin, ... J Clin Oncol 23 (23), 5347-5356, 2005 | 627 | 2005 |
| Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 … SM Swain, D Miles, SB Kim, YH Im, SA Im, V Semiglazov, E Ciruelos, ... The Lancet Oncology 21 (4), 519-530, 2020 | 599 | 2020 |
| Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus … EH Romond, JH Jeong, P Rastogi, SM Swain, CE Geyer Jr, MS Ewer, ... Journal of Clinical Oncology 30 (31), 3792, 2012 | 573 | 2012 |
| HER2 Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial EA Perez, VJ Suman, NE Davidson, S Martino, PA Kaufman, WL Lingle, ... Journal of Clinical Oncology 24 (19), 3032-3038, 2006 | 546 | 2006 |
| American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma RA Kyle, GC Yee, MR Somerfield, PJ Flynn, S Halabi, S Jagannath, ... Journal of Clinical Oncology 25 (17), 2464-2472, 2007 | 524 | 2007 |
| Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study KC Bible, VJ Suman, JR Molina, RC Smallridge, WJ Maples, ME Menefee, ... The lancet oncology 11 (10), 962-972, 2010 | 490 | 2010 |
| Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial RD Carvajal, JA Sosman, JF Quevedo, MM Milhem, AM Joshua, ... Jama 311 (23), 2397-2405, 2014 | 452 | 2014 |
| Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind … RS Herbst, R Ansari, F Bustin, P Flynn, L Hart, GA Otterson, G Vlahovic, ... The Lancet 377 (9780), 1846-1854, 2011 | 440 | 2011 |
| Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology … KJ Pandya, RF Raubertas, PJ Flynn, HE Hynes, RJ Rosenbluth, ... Annals of internal medicine 132 (10), 788-793, 2000 | 415 | 2000 |
| Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline … JA Meyerhardt, PB Mangu, PJ Flynn, L Korde, CL Loprinzi, BD Minsky, ... Journal of Clinical Oncology 31 (35), 4465-4470, 2013 | 412 | 2013 |
| Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial KJ Pandya, GR Morrow, JA Roscoe, H Zhao, JT Hickok, E Pajon, ... The Lancet 366 (9488), 818-824, 2005 | 409 | 2005 |
| Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study E Galanis, KA Jaeckle, MJ Maurer, JM Reid, MM Ames, JS Hardwick, ... Journal of clinical oncology 27 (12), 2052, 2009 | 402 | 2009 |
| Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients JL Ryan, CE Heckler, JA Roscoe, SR Dakhil, J Kirshner, PJ Flynn, ... Supportive care in cancer 20, 1479-1489, 2012 | 386 | 2012 |
